Higher level of serum vascular endothelial growth factor in type 2 diabetic patients with diabetic retinopathy hospitalized for hyperglycemic state

Yoshihiro Takamiya, Yoichi Oikawa, Hiroshi Hirose, Akira Shimada, Hiroshi Itoh

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aims: Vascular endothelial growth factor (VEGF) is a primary mediator of retinal angiogenesis, and higher levels of intraocular VEGF are observed in patients with active proliferative diabetic retinopathy. Meanwhile, whether serum VEGF level is associated with diabetic retinopathy (DR) or not is controversial. Methods: To investigate the significance of serum VEGF levels in diabetic patients with DR, we measured serum VEGF levels in 138 type 2 diabetic patients hospitalized for treatment of a hyperglycemic state, all of whom were not complicated by VEGF-related diseases, such as malignancy, cardiovascular disease or infectious disease. Results: Serum VEGF level was significantly increased in diabetic patients with DR as compared to those without DR. Moreover, multiple regression analysis and stepwise regression analysis revealed that body mass index and presence or absence of DR were associated with serum VEGF level; in particular, the presence of DR was strongly correlated with increased serum VEGF level. Conclusions: Increased serum VEGF level may be closely associated with the presence of DR in type 2 diabetic patients. Whether this conclusion is true for general type 2 diabetic patients is a subject for future investigation because of several limitations of this study, including sample selection bias.

Original languageEnglish
Pages (from-to)19-25
Number of pages7
JournalDiabetology International
Volume2
Issue number1
DOIs
Publication statusPublished - 2011 Mar

Fingerprint

Diabetic Retinopathy
Vascular Endothelial Growth Factor A
Serum
Regression Analysis
Selection Bias
Communicable Diseases
Body Mass Index
Cardiovascular Diseases

Keywords

  • Diabetic complication
  • Diabetic retinopathy
  • Type 2 diabetes
  • Vascular endothelial growth factor (VEGF)

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Higher level of serum vascular endothelial growth factor in type 2 diabetic patients with diabetic retinopathy hospitalized for hyperglycemic state. / Takamiya, Yoshihiro; Oikawa, Yoichi; Hirose, Hiroshi; Shimada, Akira; Itoh, Hiroshi.

In: Diabetology International, Vol. 2, No. 1, 03.2011, p. 19-25.

Research output: Contribution to journalArticle

@article{c6f0b86775d34e18a1d4febdc4798608,
title = "Higher level of serum vascular endothelial growth factor in type 2 diabetic patients with diabetic retinopathy hospitalized for hyperglycemic state",
abstract = "Aims: Vascular endothelial growth factor (VEGF) is a primary mediator of retinal angiogenesis, and higher levels of intraocular VEGF are observed in patients with active proliferative diabetic retinopathy. Meanwhile, whether serum VEGF level is associated with diabetic retinopathy (DR) or not is controversial. Methods: To investigate the significance of serum VEGF levels in diabetic patients with DR, we measured serum VEGF levels in 138 type 2 diabetic patients hospitalized for treatment of a hyperglycemic state, all of whom were not complicated by VEGF-related diseases, such as malignancy, cardiovascular disease or infectious disease. Results: Serum VEGF level was significantly increased in diabetic patients with DR as compared to those without DR. Moreover, multiple regression analysis and stepwise regression analysis revealed that body mass index and presence or absence of DR were associated with serum VEGF level; in particular, the presence of DR was strongly correlated with increased serum VEGF level. Conclusions: Increased serum VEGF level may be closely associated with the presence of DR in type 2 diabetic patients. Whether this conclusion is true for general type 2 diabetic patients is a subject for future investigation because of several limitations of this study, including sample selection bias.",
keywords = "Diabetic complication, Diabetic retinopathy, Type 2 diabetes, Vascular endothelial growth factor (VEGF)",
author = "Yoshihiro Takamiya and Yoichi Oikawa and Hiroshi Hirose and Akira Shimada and Hiroshi Itoh",
year = "2011",
month = "3",
doi = "10.1007/s13340-011-0019-x",
language = "English",
volume = "2",
pages = "19--25",
journal = "Diabetology International",
issn = "2190-1678",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Higher level of serum vascular endothelial growth factor in type 2 diabetic patients with diabetic retinopathy hospitalized for hyperglycemic state

AU - Takamiya, Yoshihiro

AU - Oikawa, Yoichi

AU - Hirose, Hiroshi

AU - Shimada, Akira

AU - Itoh, Hiroshi

PY - 2011/3

Y1 - 2011/3

N2 - Aims: Vascular endothelial growth factor (VEGF) is a primary mediator of retinal angiogenesis, and higher levels of intraocular VEGF are observed in patients with active proliferative diabetic retinopathy. Meanwhile, whether serum VEGF level is associated with diabetic retinopathy (DR) or not is controversial. Methods: To investigate the significance of serum VEGF levels in diabetic patients with DR, we measured serum VEGF levels in 138 type 2 diabetic patients hospitalized for treatment of a hyperglycemic state, all of whom were not complicated by VEGF-related diseases, such as malignancy, cardiovascular disease or infectious disease. Results: Serum VEGF level was significantly increased in diabetic patients with DR as compared to those without DR. Moreover, multiple regression analysis and stepwise regression analysis revealed that body mass index and presence or absence of DR were associated with serum VEGF level; in particular, the presence of DR was strongly correlated with increased serum VEGF level. Conclusions: Increased serum VEGF level may be closely associated with the presence of DR in type 2 diabetic patients. Whether this conclusion is true for general type 2 diabetic patients is a subject for future investigation because of several limitations of this study, including sample selection bias.

AB - Aims: Vascular endothelial growth factor (VEGF) is a primary mediator of retinal angiogenesis, and higher levels of intraocular VEGF are observed in patients with active proliferative diabetic retinopathy. Meanwhile, whether serum VEGF level is associated with diabetic retinopathy (DR) or not is controversial. Methods: To investigate the significance of serum VEGF levels in diabetic patients with DR, we measured serum VEGF levels in 138 type 2 diabetic patients hospitalized for treatment of a hyperglycemic state, all of whom were not complicated by VEGF-related diseases, such as malignancy, cardiovascular disease or infectious disease. Results: Serum VEGF level was significantly increased in diabetic patients with DR as compared to those without DR. Moreover, multiple regression analysis and stepwise regression analysis revealed that body mass index and presence or absence of DR were associated with serum VEGF level; in particular, the presence of DR was strongly correlated with increased serum VEGF level. Conclusions: Increased serum VEGF level may be closely associated with the presence of DR in type 2 diabetic patients. Whether this conclusion is true for general type 2 diabetic patients is a subject for future investigation because of several limitations of this study, including sample selection bias.

KW - Diabetic complication

KW - Diabetic retinopathy

KW - Type 2 diabetes

KW - Vascular endothelial growth factor (VEGF)

UR - http://www.scopus.com/inward/record.url?scp=84862870393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862870393&partnerID=8YFLogxK

U2 - 10.1007/s13340-011-0019-x

DO - 10.1007/s13340-011-0019-x

M3 - Article

AN - SCOPUS:84862870393

VL - 2

SP - 19

EP - 25

JO - Diabetology International

JF - Diabetology International

SN - 2190-1678

IS - 1

ER -